Publikace
- Potential loss of prognostic significance of minimal residual disease assessment after R-CHOP-based induction in elderly patients with mantle cell lymphoma in the era of rituximab maintenance2018 | 2. lékařská fakulta, 1. lékařská fakulta, 3. lékařská fakulta, Lékařská fakulta v Hradci Králové
- Cyclin D1 mRNA as a molecular marker for minimal residual disease monitoring in patients with mantle cell lymphoma2018 | 2. lékařská fakulta, 1. lékařská fakulta
- A novel quantitative PCR of proliferation markers (Ki-67, topoisomerase II alpha, and TPX2): an immunohistochemical correlation, testing, and optimizing for mantle cell lymphoma2010 | 2. lékařská fakulta
- Standardization of WT1 mRNA quantitation for minimal residual disease monitoring in childhood AML and implications of WT1 gene mutations: a European multicenter study2009 | 2. lékařská fakulta
- Quantitative monitoring of cyclin D1 expression: A molecular marker for minimal residual disease monitoring and a predictor of the disease outcome in patients with mantle cell lymphoma2008 | 2. lékařská fakulta
- A 5-year-old boy with super-refractory status epilepticus and RANBP2 variant warranting life-saving hemispherotomy2024 | 2. lékařská fakulta, Ústřední knihovna
- Molecular Screening in ALK-Positive Anaplastic Large Cell Lymphoma: ALK Analysis, NGS Fusion Gene Detection, and T-cell Receptor Immunoprofiling2024 | 2. lékařská fakulta, 3. lékařská fakulta
- Variant ALK-fusion positive anaplastic large cell lymphoma (ALCL): A population-based paediatric study of the NHL-BFM study group2024 | 2. lékařská fakulta, 3. lékařská fakulta
- Genetic Testing for Malformations of Cortical Development2022 | 2. lékařská fakulta
- Sekvenování nové generace - nástroj vědy či rutinní patologie?2021 | 2. léka řská fakulta, Ústřední knihovna
Loading network view...